000 01728 a2200457 4500
005 20250514041615.0
264 0 _c20030417
008 200304s 0 0 eng d
022 _a0213-3911
024 7 _a10.14670/HH-17.739
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aReis, F M
245 0 0 _aRegulation of human endometrial transforming growth factor beta1 and beta3 isoforms through menstrual cycle and medroxyprogesterone acetate treatment.
_h[electronic resource]
260 _bHistology and histopathology
_c2002
300 _a739-45 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aCell Differentiation
650 0 4 _aDNA, Complementary
_xmetabolism
650 0 4 _aEndometrium
_xmetabolism
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Developmental
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aMedroxyprogesterone Acetate
_xpharmacology
650 0 4 _aMenstrual Cycle
650 0 4 _aProgesterone Congeners
_xpharmacology
650 0 4 _aProgestins
_xbiosynthesis
650 0 4 _aProtein Isoforms
650 0 4 _aRNA
_xmetabolism
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aTime Factors
650 0 4 _aTransforming Growth Factor beta
_xbiosynthesis
650 0 4 _aTransforming Growth Factor beta1
650 0 4 _aTransforming Growth Factor beta3
700 1 _aRibeiro, M F M
700 1 _aMaia, A L
700 1 _aSpritzer, P M
773 0 _tHistology and histopathology
_gvol. 17
_gno. 3
_gp. 739-45
856 4 0 _uhttps://doi.org/10.14670/HH-17.739
_zAvailable from publisher's website
999 _c12051686
_d12051686